Efficacy of a single intravenous administration of laninamivir (an active metabolite of laninamivir octanoate) in an influenza virus infection mouse modelArticle Published on 2013-10-012023-06-24 Journal: Antiviral Research [Category] 신종인플루엔자, [키워드] 50% mouse lethal dose area under curve AUC bovine serum albumin BSA days postinfection DPI FBS fetal bovine serum half-life hours postinfection hpi Influenza Intravenous administration laninamivir Madin–Darby canine kidney MDCK mean residence time MLD(50) mouse model MRT neuraminidase inhibitor PBS pfu Phosphate Buffered Saline plaque forming unit t(1/2). [DOI] 10.1016/j.antiviral.2013.08.004